Skip to main content
. 2022 Apr 18;20(4):271. doi: 10.3390/md20040271

Figure 3.

Figure 3

Molecular structure of various phytoplankton-derived bioactive compounds and toxins with potential therapeutic effects: (a) Gambieric acid; (b) Goniodomin-A; (c) Amphidinolide-H; (d) Amphidinol-3 (AM3); (e) Ceramide; (f) Symbioramide; (g) Ciguatoxin; (h) Palytoxin; (i) Yessotoxin; (j) Okadaic acid.